International E-publication: Publish Projects, Dissertation, Theses, Books, Souvenir, Conference Proceeding with ISBN. 

Nature's Pharmacy: Avocado (Persea americana Mill.) Leaves as a Novel Therapeutic Agent for Diabetes, Hypertension, High Cholesterol, Gastric Ulcers, Kidney Stones and Gout

Author Affiliations

  • 1Department of Food Science and Technology, Collage of Agriculture and Food Technology, University of Dar es Salaam P.O. Box 35134, Dares Salaam, Tanzania

Int. Res. J. Biological Sci., Volume 13, Issue (3), Pages 27-32, August,10 (2024)

Abstract

Non-communicable diseases originating from a combination of genetic, physiological, environmental and behavioural factors are threatening livelihoods of mankind. They kill approximately 41 million people each year, equivalent to 74% of all deaths globally. Avocado leaves harbour bioactive substances that could help managing a range of non-communicable diseases. The aim of this article is to review the therapeutic potential of such leaves in managing diabetes, hypertension, high cholesterol, kidney stones, gastric ulcers and gout. Avocado leaf extracts at a dosage of 100 mg/kg/day effectively reduced blood glucose levels in diabetic rats and thus managed type 2 diabetes throughout a four-week treatment period. The extracts managed hypertension by lowering systolic blood pressure from 164.9 ± 7.2 to 116.8 ± 6.4 mmHg and diastolic blood pressure from 118.4 ± 16.2 to 82.8 ± 6.5 mmHg. The extracts regulated plasma cholesterol levels by increasing high-density lipoprotein cholesterol (good cholesterol) and lowering total cholesterol, triglycerides and high-density lipoprotein cholesterol (bad cholesterol). Additionally, the extracts prevented oxidant damage and crystal formation and deposits in the white rat kidneys. The extract managed gastric ulcers by reducing gastric acid secretion and ulcer count/index. As for the management of gout, avocado leaf extract demonstrated ability of lowering blood uric acid content (from 12.3 to 4.3%) whose higher levels result into gout. This suggests that avocado leaf could be processed into conventional drugs for managing such non communicable diseases.

References

  1. Kim, H. C., & Oh, S. M. (2013)., Noncommunicable diseases: current status of major modifiable risk factors in Korea., Journal of preventive medicine and public health, 46(4), 165.
  2. World Health Organization (WHO) (2023)., Noncommunicable diseases., Available online: https://www.who.int/news-room/fact-sheets/detail/ noncommunicable-diseases. (Accessed on 24th April, 2024).
  3. World Health Organization (WHO) (2023)., Diabetes., Available online: https://www.who.int/news-room/fact-sheets/detail/diabetes (Accessed on 24th April, 2024).
  4. World Health Organization (WHO) (2023)., Hypertension., Available online: https://www.who.int/ news-room/fact-sheets/detail/ hypertension. (Accessed on 24th April, 2024).
  5. Franklin, S. S., Larson, M. G., Khan, S. A., Wong, N. D., Leip, E. P., Kannel, W. B., & Levy, D. (2001)., Does the relation of blood pressure to coronary heart disease risk change with aging?., The Framingham Heart Study. Circulation, 103(9), 1245-1249.
  6. Clifford, J., & Kozil, A. (2012)., Dietary fat and cholesterol., Colorado State University.
  7. Ma, H., & Shieh, K. J. (2006)., Cholesterol and human health., The Journal of American Science, 2(1), 46-50.
  8. Tabas, I. (2002). Cholesterol in health and disease. The Journal of clinical investigation, 110(5), 583-590., undefined, undefined
  9. Zheng, J., Wang, J., Zhang, Y., Xia, J., Guo, H., Hu, H., ... & Li, T. (2022)., The Global Burden of Diseases attributed to high low-density lipoprotein cholesterol from 1990 to 2019., Frontiers in public health, 10, 891929.
  10. Zaidi, S. R. H., & Sharma, S. S. (2022)., Stat Pearls Publishing; Treasure Island., FL, USA: 2022. Pressure Ulcer.
  11. Serena, S., Michele, R., Chiara, M., Gioacchino, L., Lorella, F., Tiziana, M., & Gian, L. D. A. (2018)., Relationship between Helicobacter pylori infection and GERD., Acta Bio Medica: Atenei Parmensis, 89(Suppl 8), 40.
  12. Shah, J., & Whitfield, H. N. (2002)., Urolithiasis through the ages., BJU international, 89(8).
  13. Nikpay, S., Moradi, K., Azami, M., Babashahi, M., Otaghi, M., & Borji, M. (2016)., Frequency of kidney stone different compositions in patients referred to a Lithotripsy Center in Ilam, West of Iran., Journal of Pediatric Nephrology, 4(3), 102-107.
  14. Romero, V., Akpinar, H., & Assimos, D. G. (2010)., Kidney stones: a global picture of prevalence, incidence, and associated risk factors., Reviews in urology, 12(2-3), e86.
  15. Stamatelou, K., & Goldfarb, D. S. (2023)., Epidemiology of kidney stones., In Healthcare, 11(3), 424. MDPI.
  16. Bowen‐Davies, Z., Muller, S., Mallen, C. D., Hayward, R. A., & Roddy, E. (2018)., Gout severity, socioeconomic status, and work absence: a cross‐sectional study in primary care., Arthritis care & research, 70(12), 1822-1828.
  17. Luo, L., Xiang, Q., Deng, Y., Zhao, S., Zhu, Z., Liu, Y., ... & Zhao, Z. (2019)., Gout is associated with elevated risk of erectile dysfunction: a systematic review and meta-analysis., Rheumatology international, 39, 1527-1535.
  18. Cipolletta, E., Tata, L. J., Nakafero, G., Avery, A. J., Mamas, M. A., & Abhishek, A. (2022)., Association between gout flare and subsequent cardiovascular events among patients with gout., Jama, 328(5), 440-450.
  19. Onuora, S. (2020)., Hospitalization for infection on the rise in gout., Nature Reviews Rheumatology, 16(6), 296-296.
  20. Chiou, W. K., Wang, M. H., Huang, D. H., Chiu, H. T., Lee, Y. J., & Lin, J. D. (2010)., The relationship between serum uric acid level and metabolic syndrome: differences by sex and age in Taiwanese., Journal of Epidemiology, 20(3), 219-224.
  21. Zhang, J., Jin, C., Ma, B., Sun, H., Chen, Y., Zhong, Y., ... & Li, Y. (2023)., Global, regional and national burdens of gout in the young population from 1990 to 2019: a population-based study., RMD Open, 9(2), e003025.
  22. Fithria, F., Husna, C., Ahyana, A., Nurhidayah, I., & Jannah, S. R. (2022)., Self-management Effectiveness on the Quality of Life of Type 2 Diabetes Mellitus Patients during the COVID-19 Pandemic in Aceh, Indonesia., Open Access Macedonian Journal of Medical Sciences, 10(G), 492-498.
  23. Zimmerman, R. S. (2014)., More than just cardiovascular risk?., Cleveland Clinic Journal of Medicine, 81(11), 673.
  24. Rahman, N. (2023)., The Effect of Giving Avocado Leaf and Seed Extract as Antidiabetes: A Systematic Literature Review., Jurnal Gizi Kerja dan Produktivitas, 4(1), 81-94.
  25. Brai, B. I., Odetola, A. A., & Agomo, P. U. (2007)., Hypoglycemic and hypocholesterolemic potential of Persea americana leaf extracts., Journal of Medicinal Food, 10(2), 356-360.
  26. Princwill-Ogbonna, I. L., Ogbonna, P. C., & Ogujiofor, I. B. (2019)., Proximate composition, vitamin, mineral and biologically active compounds levels in leaves of Mangifera indica (Mango), Persea americana (Avocado pea), and Annona muricata (Sour sop)., Journal of Applied Sciences and Environmental Management, 23(1), 65-74.
  27. Abd Elkader, A. M., Labib, S., Taha, T. F., Althobaiti, F., Aldhahrani, A., Salem, H. M., ... & Ibrahim, F. M. (2022)., Phytogenic compounds from avocado (Persea americana L.) extracts; antioxidant activity, amylase inhibitory activity, therapeutic potential of type 2 diabetes., Saudi Journal of Biological Sciences, 29(3), 1428-1433.
  28. Lima, C. R., Vasconcelos, C. F. B., Costa-Silva, J. H., Maranhão, C. A., Costa, J., Batista, T. M., ... & Wanderley, A. G. (2012)., Anti-diabetic activity of extract from Persea americana Mill. leaf via the activation of protein kinase B (PKB/Akt) in streptozotocin-induced diabetic rats., Journal of Ethnopharmacology, 141(1), 517-525.
  29. Antia, B. S., Okokon, J. E., & Okon, P. A. (2005)., Hypoglycemic activity of aqueous leaf extract of Persea americana Mill., Indian Journal of Pharmacology, 37(5), 325-326.
  30. Kouamé, N. G. M., Koffi, C., N’Zoué, K. S., Yao, N., Doukouré, B., & Kamagaté, M. (2019)., Comparative antidiabetic activity of aqueous, ethanol, and methanol leaf extracts of Persea americana and their effectiveness in type 2 diabetic rats., Evidence-Based Complementary and Alternative Medicine.
  31. Ojewole, J., Kamadyaapa, D. R., Gondwe, M. M., Moodley, K., & Musabayane, C. T. (2007)., Cardiovascular effects of Persea americana Mill (Lauraceae)(avocado) aqueous leaf extract in experimental animals., Cardiovascular Journal of South Africa, 18(2), 69–76.
  32. Sutiningsih, D., Sari, D. P., Adi, M. S., Hadi, M., & Azzahra, N. A. (2023)., Effectiveness of avocado leaf extract (Persea americana Mill.) as antihypertensive., F1000Research, 11, 1100.
  33. Brai, B. I. C., Falode, J. A., Adisa, R. A., & Odetola, A. A. (2020)., Effects of aqueous leaf extract of avocado (Persea americana) on total cholesterol, triacylglycerols, protein and haematological parameters in CCl4-intoxicated rats., Clinical Phytoscience, 6, 1-6.
  34. Kolawole, O. T., Kolawole, S. O., Ayankunle, A. A., & Olaniran, I. O. (2012)., Methanol leaf extract of Persea americana protects rats against cholesterol-induced hyperlipidemia., British Journal of Medicine and Medical Research, 2(2), 235-242.
  35. Erdem, G., Kesik, V., Honca, T., Özcan, A., Uğuz, S., Aykutlug, Ö., Alp, B.F., Korkmazer, N., Saldir, M. & Bayrak, Z. (2016)., Antinephrolithiatic activity of Persea americana (avocado) and Viburnum opulus (guelder rose) against ethylene glycol-induced nephrolithiasis in rats., African Journal of Traditional, Complementary and Alternative Medicines, 13(2), 110-119.
  36. Wientarsih, I., Madyastuti, R., Prasetyo, B. F., & Aldobrata, A. (2012)., Anti lithiasis activity of avocado (Persea americana Mill) leaves extract in white male rats., Hayati Journal of Biosciences, 19(1), 49-52.
  37. Sandhiutami, N. M. D., Dewi, R. S., & Fariha, A. (2022)., The effectiveness of avocado (Persea americana M.) leaves infusion as urinary stones dissolving in rats., Pharmaciana, 12(2), 164-172.
  38. Owoyele, B. V., Adebayo, I. K., & Soladoye, A. O. (2015)., Anti-ulcer effects of aqueous extract of Persea americana Mill (Avocado) leaves in rats., Comp. Bio. Nat. Pro, 3, 179-184.
  39. Simbolon, R. O., Dalimunthe, A., Bangun, H., Harahap, U., & Arianto, A. (2023)., The effect of avocado leaf ethanol extract (Persea Americana Mill) on aspirin-induced reduction of gastric acid in rats., Journal La Medihealtico, 4(5), 247-257.
  40. Amis, R. T., Ginting, C. N., Ferdinand, S., & Ikhtiari, R. (2021)., Anti-hyperuricemia of avocado leaves ethanol extract in potassium oxonate induced-rats., In Proceedings of the 2021 IEEE International Conference on Health, Instrumentation & Measurement, and Natural Sciences, Medan, Indonesia, 14–16 July. 1–5.